Sarah Romano - Chief Financial Officer, Eyegate Pharmaceuticals Inc

As of November 3, 2021


Sarah Romano Net Worth

  • Net worth is estimated to be at least $165.09K
  • Owns at least 262,113 units of Eyegate Pharmaceuticals Inc stock
  • Sold an estimated value of $26.67K in the last 4 years at Eyegate Pharmaceuticals Inc

Sarah Romano Compensation at Eyegate Pharmaceuticals Inc in 2020

  • Earned a $264,361 salary and a $60 bonus
  • Rewarded $64,641 in stock value and options
  • Received a total compensation of $453,643

Sarah Romano Trading

  • Largest purchase of shares was 10,000 units , worth over $10K on August 17, 2017
  • Largest sale of shares was 19,750 units , worth over $4.67K on July 15, 2019
  • In total has made about 38 transactions over 4 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Sarah Romano Mailing Address

  • Mailing address is 271 Waverly Oaks Road Waltham MA 02452 MA

Eyegate Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Stephen From 2020 $400,000 $160,000 $129,282 $193,923 - $883,205
Stephen From 2019 $400,000 $106,600 - $94,740 - $601,340
Sarah Romano 2020 $264,361 $60,000 $64,641 $64,641 - $453,643
Sarah Romano 2019 $250,000 $86,010 - $23,685 - $359,695
Michael Manzo 2020 $250,000 $60,000 $48,481 $48,481 - $406,962
Michael Manzo 2019 $250,000 $94,167 - $23,685 - $367,852
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1372514/000110465921058990/tm2114484-1_def14a.htm

Eyegate Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 260,963 units sold on August 3, 2021 by Armistice Capital Llc, Armistice Capital Master Fund Ltd and Steven Boyd worth over $646.61K
  • In the last 6 years, insiders at Eyegate Pharmaceuticals Inc sold an estimated value of $15.73M and bought an estimated value of $20.29M
  • The most active traders are Stephen From, Executive Chairman,  Michael Manzo, VP Engineering,  and Brenda Mann, VP Research & Development
  • Insider trading is most common in February, with the busiest year in 2020

EYEGATE PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1